Disease Markers

Disease Markers / 2010 / Article
Special Issue

Systems Biology of Biomarkers

View this Special Issue

Open Access

Volume 28 |Article ID 240248 | https://doi.org/10.3233/DMA-2010-0705

Bridget Wilson, Lance A. Liotta, Emanuel Petricoin III, "Monitoring Proteins and Protein Networks Using Reverse Phase Protein Arrays", Disease Markers, vol. 28, Article ID 240248, 8 pages, 2010. https://doi.org/10.3233/DMA-2010-0705

Monitoring Proteins and Protein Networks Using Reverse Phase Protein Arrays

Received31 May 2010
Accepted31 May 2010


Recent advances in high throughput, high content “omic” technologies coupled with clinical information has lead to the expectation that the complexity of the molecular information generated will lead to more robust scientific research as well as the expectation that overarching therapeutic approaches will be patient-tailored to the underlying specific molecular defects of the disease. As disease understanding progresses and more therapeutics, which predominately target proteins, are developed there is a need to more confidently determine the protein signaling events that can be correlated with drug response since the deranged protein signaling networks are often the drug target itself. In this environment, the Reverse Phase Protein Microarray (RPMA) can be utilized to address the needs of both clinical screening and disease understanding through its ability to provide an unmatched functional and highly multiplexed signaling network level mapping of ongoing signaling activation, coupled with the ability of the platform to provide this information reproducibly from a tiny needle biopsy specimen or fine needle aspirate. This platform has now been utilized for biomarker discovery/validation and advancements in disease understanding both in the clinic and at the bench in the fields of cancer, liver disease, immunological disorders, and bacterial infection.

Copyright © 2010 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Order printed copiesOrder

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.